The prospect of artificial intelligence to personalize assisted reproductive technology.

Authors:
Hanassab S; Abbara A; Yeung AC; Voliotis M; Tsaneva-Atanasova K and 5 more

Journal:
NPJ Digit Med

Publication Year: 2024

DOI:
10.1038/s41746-024-01006-x

PMCID:
PMC10907618

PMID:
38429464

Journal Information

Journal Title: NPJ Digit Med

Detailed journal information not available.

Publication Details

Subject Category: Medical Informatics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests A.A. has received grants from the BRC; and has provided consulting services for Myovant Sciences Ltd. G.H.T. has stock in TFP; has received honoraria and travel support from Ferring Pharmaceuticals; and has provided consultancy services to ARC Medical Inc. S.M.N. received grants from NIHR, CSO, and BRC; provided consultancy services for Access Fertility, Modern Fertility, TFP, and Ferring Pharmaceuticals; received honoraria from Ferring Pharmaceuticals and Merck; received support for attending meetings and/or travel from Ferring Pharmaceuticals and Merck; participated in a data safety monitoring board or advisory board for NIHR; owns stock or stock options in TFP. W.S.D. received grants from NIHR, MRC, and Imperial Health Charity, and is a Consultant for Myovant Sciences Ltd. The remaining authors declare no competing interests."

Evidence found in paper:

"The Department of Metabolism, Digestion, and Reproduction is funded by grants from the MRC and NIHR. S.H. is supported by the UKRI CDT in AI for Healthcare http://ai4health.io (EP/S023283/1). A.A. is supported by an NIHR Clinician Scientist Award (CS-2018-18-ST2-002). M.V. and K.T.A. are supported by the EPSRC (EP/T017856/1). W.S.D. is supported by an NIHR Senior Investigator Award (NIHR202371). Competing interests: A.A. has received grants from the BRC; and has provided consulting services for Myovant Sciences Ltd. G.H.T. has stock in TFP; has received honoraria and travel support from Ferring Pharmaceuticals; and has provided consultancy services to ARC Medical Inc. S.M.N. received grants from NIHR, CSO, and BRC; provided consultancy services for Access Fertility, Modern Fertility, TFP, and Ferring Pharmaceuticals; received honoraria from Ferring Pharmaceuticals and Merck; received support for attending meetings and/or travel from Ferring Pharmaceuticals and Merck; participated in a data safety monitoring board or advisory board for NIHR; owns stock or stock options in TFP. W.S.D. received grants from NIHR, MRC, and Imperial Health Charity, and is a Consultant for Myovant Sciences Ltd. The remaining authors declare no competing interests."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025